Glimepiride
Glimepiride is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea. Glimepiride distinctly lower the blood glucose level by both defects of diabetes mellitus type 2, by stimulating pancreatic beta cells to produce more insulin and induced increased activity of peripheral insulin intra cellular receptor.
drukujBioton WorldWide
Requires the Flash plugin. If the plugin is already installed, click here.
GPW
Contact for media:
Jacek Zawadzkijzawadzki@egzogroup.pl
Mobile: +48 694 400 222
Contact for investors:
Jacek Zawadzkijzawadzki@egzogroup.pl
Mobile: +48 694 400 222
